Cargando…
Thioredoxin-Interacting Protein in Cancer and Diabetes
SIGNIFICANCE: Thioredoxin-interacting protein (Txnip) is an α-arrestin protein that acts as a cancer suppressor. Txnip is simultaneously a critical regulator of energy metabolism. Other alpha-arrestin proteins also play key roles in cell biology and cancer. RECENT ADVANCES: Txnip expression is regul...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125520/ https://www.ncbi.nlm.nih.gov/pubmed/34384271 http://dx.doi.org/10.1089/ars.2021.0038 |
_version_ | 1784711954293587968 |
---|---|
author | Masutani, Hiroshi |
author_facet | Masutani, Hiroshi |
author_sort | Masutani, Hiroshi |
collection | PubMed |
description | SIGNIFICANCE: Thioredoxin-interacting protein (Txnip) is an α-arrestin protein that acts as a cancer suppressor. Txnip is simultaneously a critical regulator of energy metabolism. Other alpha-arrestin proteins also play key roles in cell biology and cancer. RECENT ADVANCES: Txnip expression is regulated by multilayered mechanisms, including transcriptional regulation, microRNA, messenger RNA (mRNA) stabilization, and protein degradation. The Txnip-based connection between cancer and metabolism has been widely recognized. Meanwhile, new aspects are proposed for the mechanism of action of Txnip, including the regulation of RNA expression and autophagy. Arrestin domain containing 3 (ARRDC3), another α-arrestin protein, regulates endocytosis and signaling, whereas ARRDC1 and ARRDC4 regulate extracellular vesicle formation. CRITICAL ISSUES: The mechanism of action of Txnip is yet to be elucidated. The regulation of intracellular protein trafficking by arrestin family proteins has opened an emerging field of biology and medical research, which needs to be examined further. FUTURE DIRECTIONS: A fundamental understanding of the mechanism of action of Txnip and other arrestin family members needs to be explored in the future to combat diseases such as cancer and diabetes. Antioxid. Redox Signal. 36, 1001–1022. |
format | Online Article Text |
id | pubmed-9125520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-91255202022-05-23 Thioredoxin-Interacting Protein in Cancer and Diabetes Masutani, Hiroshi Antioxid Redox Signal Article SIGNIFICANCE: Thioredoxin-interacting protein (Txnip) is an α-arrestin protein that acts as a cancer suppressor. Txnip is simultaneously a critical regulator of energy metabolism. Other alpha-arrestin proteins also play key roles in cell biology and cancer. RECENT ADVANCES: Txnip expression is regulated by multilayered mechanisms, including transcriptional regulation, microRNA, messenger RNA (mRNA) stabilization, and protein degradation. The Txnip-based connection between cancer and metabolism has been widely recognized. Meanwhile, new aspects are proposed for the mechanism of action of Txnip, including the regulation of RNA expression and autophagy. Arrestin domain containing 3 (ARRDC3), another α-arrestin protein, regulates endocytosis and signaling, whereas ARRDC1 and ARRDC4 regulate extracellular vesicle formation. CRITICAL ISSUES: The mechanism of action of Txnip is yet to be elucidated. The regulation of intracellular protein trafficking by arrestin family proteins has opened an emerging field of biology and medical research, which needs to be examined further. FUTURE DIRECTIONS: A fundamental understanding of the mechanism of action of Txnip and other arrestin family members needs to be explored in the future to combat diseases such as cancer and diabetes. Antioxid. Redox Signal. 36, 1001–1022. Mary Ann Liebert, Inc., publishers 2022-05-01 2022-05-06 /pmc/articles/PMC9125520/ /pubmed/34384271 http://dx.doi.org/10.1089/ars.2021.0038 Text en © Hiroshi Masutani, 2022; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by-nc/4.0/This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License [CC-BY-NC] (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are cited. |
spellingShingle | Article Masutani, Hiroshi Thioredoxin-Interacting Protein in Cancer and Diabetes |
title | Thioredoxin-Interacting Protein in Cancer and Diabetes |
title_full | Thioredoxin-Interacting Protein in Cancer and Diabetes |
title_fullStr | Thioredoxin-Interacting Protein in Cancer and Diabetes |
title_full_unstemmed | Thioredoxin-Interacting Protein in Cancer and Diabetes |
title_short | Thioredoxin-Interacting Protein in Cancer and Diabetes |
title_sort | thioredoxin-interacting protein in cancer and diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125520/ https://www.ncbi.nlm.nih.gov/pubmed/34384271 http://dx.doi.org/10.1089/ars.2021.0038 |
work_keys_str_mv | AT masutanihiroshi thioredoxininteractingproteinincanceranddiabetes |